ANCAs recognize other epitopes than PR-1; T-cell lines established from PR-3/ANCA-positive patients with Wegener's disease do not recognize T2 cells pulsed with PR-1; Normal myeloid cells ...

The effective targeting of RAS-mutant acute myeloid leukemia (AML) still remains a challenge; RAS mutations are tied to relapse to targeted therapy, such as resistance to FLT3 inhibitors due to the ...

Kura Oncology, Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor ziftomenib showed encouraging data across ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Acute myeloid leukemia is a type of cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer develops from myeloid blasts cells that would ...

Epilepsy, the most common neurological disorder, is characterized by seizures resulting from an imbalance between brain ...

A retrospective analysis reveals that tyrosine kinase inhibitors offer a promising pathway for managing chronic myeloid leukemia in patients ages 75 and older, with increases in major molecular ...

The FDA has granted fast track designation to LBS-007 for the treatment of patients with acute myeloid leukemia.

Mitochondria are pivotal cellular organelles that play a crucial role in regulating metabolism and cell survival, making them ...

University of Cincinnati Cancer Center experts will present abstracts at the 66th American Society of Hematology (ASH) Annual ...